New Foam Treatment Effective for Moderate to Severe Acne

08/30/2018

A recent study found that a topical minocycline foam, FMX 101 4%, was safe and effective for the treatment of moderate to severe acne.

The 2 identical phase 3 studies included a total of 961 participants with moderate to severe acne vulgaris. Participants were randomized to once-daily FMX 101 4% foam or vehicle for 12 weeks. Changes in inflammatory lesion count from baseline to week 12 and treatment success rate, defined as Investigator’s Global Assessment score of 0 or 1 (clear or almost clear), at week 12 were assessed as the primary endpoints.